argenx SE | ARGX - PE Price to Earnings


argenx SE reported 43.02 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AstraZeneca 27.29 5.8 Dec/2025
Galapagos 3.14 50.78 Dec/2025
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
UCB 29.7 5.52 Dec/2025